Copyright Reports & Markets. All rights reserved.

Global Injectable Drug Delivery Devices Market Research Report 2021

Request for Sample of this report
Buy now

1 Injectable Drug Delivery Devices Market Overview

  • 1.1 Product Overview and Scope of Injectable Drug Delivery Devices
  • 1.2 Injectable Drug Delivery Devices Segment by Type
    • 1.2.1 Global Injectable Drug Delivery Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Devices
    • 1.2.3 Formulation
  • 1.3 Injectable Drug Delivery Devices Segment by Application
    • 1.3.1 Injectable Drug Delivery Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Immune Disorder
    • 1.3.3 Cancer
    • 1.3.4 Diabetes
    • 1.3.5 Other
  • 1.4 Global Injectable Drug Delivery Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Injectable Drug Delivery Devices Revenue 2016-2027
    • 1.4.2 Global Injectable Drug Delivery Devices Sales 2016-2027
    • 1.4.3 Injectable Drug Delivery Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Injectable Drug Delivery Devices Market Competition by Manufacturers

  • 2.1 Global Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Injectable Drug Delivery Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Injectable Drug Delivery Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Injectable Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Injectable Drug Delivery Devices Market Competitive Situation and Trends
    • 2.5.1 Injectable Drug Delivery Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Devices Players Market Share by Revenue
    • 2.5.3 Global Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Drug Delivery Devices Retrospective Market Scenario by Region

  • 3.1 Global Injectable Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Injectable Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Injectable Drug Delivery Devices Market Facts & Figures by Country
    • 3.3.1 North America Injectable Drug Delivery Devices Sales by Country
    • 3.3.2 North America Injectable Drug Delivery Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Injectable Drug Delivery Devices Market Facts & Figures by Country
    • 3.4.1 Europe Injectable Drug Delivery Devices Sales by Country
    • 3.4.2 Europe Injectable Drug Delivery Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Injectable Drug Delivery Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Injectable Drug Delivery Devices Sales by Region
    • 3.5.2 Asia Pacific Injectable Drug Delivery Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Injectable Drug Delivery Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Injectable Drug Delivery Devices Sales by Country
    • 3.6.2 Latin America Injectable Drug Delivery Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Injectable Drug Delivery Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Injectable Drug Delivery Devices Sales by Country
    • 3.7.2 Middle East and Africa Injectable Drug Delivery Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Injectable Drug Delivery Devices Historic Market Analysis by Type

  • 4.1 Global Injectable Drug Delivery Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Injectable Drug Delivery Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Injectable Drug Delivery Devices Price by Type (2016-2021)

5 Global Injectable Drug Delivery Devices Historic Market Analysis by Application

  • 5.1 Global Injectable Drug Delivery Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Injectable Drug Delivery Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Injectable Drug Delivery Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Dickinson and Company
    • 6.1.1 Dickinson and Company Corporation Information
    • 6.1.2 Dickinson and Company Description and Business Overview
    • 6.1.3 Dickinson and Company Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Dickinson and Company Product Portfolio
    • 6.1.5 Dickinson and Company Recent Developments/Updates
  • 6.2 Baxter International
    • 6.2.1 Baxter International Corporation Information
    • 6.2.2 Baxter International Description and Business Overview
    • 6.2.3 Baxter International Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Baxter International Product Portfolio
    • 6.2.5 Baxter International Recent Developments/Updates
  • 6.3 Schott
    • 6.3.1 Schott Corporation Information
    • 6.3.2 Schott Description and Business Overview
    • 6.3.3 Schott Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Schott Product Portfolio
    • 6.3.5 Schott Recent Developments/Updates
  • 6.4 Eli Lilly
    • 6.4.1 Eli Lilly Corporation Information
    • 6.4.2 Eli Lilly Description and Business Overview
    • 6.4.3 Eli Lilly Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Eli Lilly Product Portfolio
    • 6.4.5 Eli Lilly Recent Developments/Updates
  • 6.5 Pfizer
    • 6.5.1 Pfizer Corporation Information
    • 6.5.2 Pfizer Description and Business Overview
    • 6.5.3 Pfizer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Pfizer Product Portfolio
    • 6.5.5 Pfizer Recent Developments/Updates
  • 6.6 Gerresheimer
    • 6.6.1 Gerresheimer Corporation Information
    • 6.6.2 Gerresheimer Description and Business Overview
    • 6.6.3 Gerresheimer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Gerresheimer Product Portfolio
    • 6.6.5 Gerresheimer Recent Developments/Updates
  • 6.7 Terumo Corporation
    • 6.6.1 Terumo Corporation Corporation Information
    • 6.6.2 Terumo Corporation Description and Business Overview
    • 6.6.3 Terumo Corporation Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Terumo Corporation Product Portfolio
    • 6.7.5 Terumo Corporation Recent Developments/Updates
  • 6.8 Antares Pharma
    • 6.8.1 Antares Pharma Corporation Information
    • 6.8.2 Antares Pharma Description and Business Overview
    • 6.8.3 Antares Pharma Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Antares Pharma Product Portfolio
    • 6.8.5 Antares Pharma Recent Developments/Updates
  • 6.9 Novo Nordik
    • 6.9.1 Novo Nordik Corporation Information
    • 6.9.2 Novo Nordik Description and Business Overview
    • 6.9.3 Novo Nordik Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Novo Nordik Product Portfolio
    • 6.9.5 Novo Nordik Recent Developments/Updates
  • 6.10 Sanofi
    • 6.10.1 Sanofi Corporation Information
    • 6.10.2 Sanofi Description and Business Overview
    • 6.10.3 Sanofi Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Sanofi Product Portfolio
    • 6.10.5 Sanofi Recent Developments/Updates
  • 6.11 Unilife Corporation
    • 6.11.1 Unilife Corporation Corporation Information
    • 6.11.2 Unilife Corporation Injectable Drug Delivery Devices Description and Business Overview
    • 6.11.3 Unilife Corporation Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Unilife Corporation Product Portfolio
    • 6.11.5 Unilife Corporation Recent Developments/Updates
  • 6.12 Zogenix
    • 6.12.1 Zogenix Corporation Information
    • 6.12.2 Zogenix Injectable Drug Delivery Devices Description and Business Overview
    • 6.12.3 Zogenix Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Zogenix Product Portfolio
    • 6.12.5 Zogenix Recent Developments/Updates
  • 6.13 Hospira
    • 6.13.1 Hospira Corporation Information
    • 6.13.2 Hospira Injectable Drug Delivery Devices Description and Business Overview
    • 6.13.3 Hospira Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Hospira Product Portfolio
    • 6.13.5 Hospira Recent Developments/Updates
  • 6.14 Presage Bioscience
    • 6.14.1 Presage Bioscience Corporation Information
    • 6.14.2 Presage Bioscience Injectable Drug Delivery Devices Description and Business Overview
    • 6.14.3 Presage Bioscience Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Presage Bioscience Product Portfolio
    • 6.14.5 Presage Bioscience Recent Developments/Updates
  • 6.15 MicroCHIPS
    • 6.15.1 MicroCHIPS Corporation Information
    • 6.15.2 MicroCHIPS Injectable Drug Delivery Devices Description and Business Overview
    • 6.15.3 MicroCHIPS Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 MicroCHIPS Product Portfolio
    • 6.15.5 MicroCHIPS Recent Developments/Updates
  • 6.16 Pearl Therapeutics
    • 6.16.1 Pearl Therapeutics Corporation Information
    • 6.16.2 Pearl Therapeutics Injectable Drug Delivery Devices Description and Business Overview
    • 6.16.3 Pearl Therapeutics Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Pearl Therapeutics Product Portfolio
    • 6.16.5 Pearl Therapeutics Recent Developments/Updates
  • 6.17 Genentech
    • 6.17.1 Genentech Corporation Information
    • 6.17.2 Genentech Injectable Drug Delivery Devices Description and Business Overview
    • 6.17.3 Genentech Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Genentech Product Portfolio
    • 6.17.5 Genentech Recent Developments/Updates
  • 6.18 Bend Research
    • 6.18.1 Bend Research Corporation Information
    • 6.18.2 Bend Research Injectable Drug Delivery Devices Description and Business Overview
    • 6.18.3 Bend Research Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Bend Research Product Portfolio
    • 6.18.5 Bend Research Recent Developments/Updates

7 Injectable Drug Delivery Devices Manufacturing Cost Analysis

  • 7.1 Injectable Drug Delivery Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Injectable Drug Delivery Devices
  • 7.4 Injectable Drug Delivery Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Injectable Drug Delivery Devices Distributors List
  • 8.3 Injectable Drug Delivery Devices Customers

9 Injectable Drug Delivery Devices Market Dynamics

  • 9.1 Injectable Drug Delivery Devices Industry Trends
  • 9.2 Injectable Drug Delivery Devices Growth Drivers
  • 9.3 Injectable Drug Delivery Devices Market Challenges
  • 9.4 Injectable Drug Delivery Devices Market Restraints

10 Global Market Forecast

  • 10.1 Injectable Drug Delivery Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Injectable Drug Delivery Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Injectable Drug Delivery Devices by Type (2022-2027)
  • 10.2 Injectable Drug Delivery Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Injectable Drug Delivery Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Injectable Drug Delivery Devices by Application (2022-2027)
  • 10.3 Injectable Drug Delivery Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Injectable Drug Delivery Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Injectable Drug Delivery Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Devices
    Formulation

    Segment by Application
    Immune Disorder
    Cancer
    Diabetes
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Dickinson and Company
    Baxter International
    Schott
    Eli Lilly
    Pfizer
    Gerresheimer
    Terumo Corporation
    Antares Pharma
    Novo Nordik
    Sanofi
    Unilife Corporation
    Zogenix
    Hospira
    Presage Bioscience
    MicroCHIPS
    Pearl Therapeutics
    Genentech
    Bend Research

    Buy now